Genasys Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $56.9M+137.0% YoYTTM through 30 Jun 2026
Net Income -$6.2MTTM through 30 Jun 2026
Free Cash Flow -$2.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 63.3% |
| EBITDA Margin | 1.8% |
| Operating Margin | 8.4% |
| Net Margin | -10.9% |
Returns
468.1%ROE
-10.6%ROA
Balance Sheet Health
Debt / Equity4.83x
Current Ratio0.82x
Net Debt$13.6M
Cash & Equivalents$3.1M
Quality Metrics
Altman Z-Score-1.78
Piotroski F-Score5 / 9
FCF Margin-4.6%
Rule of 4020.6
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $40.8M
Diluted EPS-$0.14TTMFY2025: $-0.40
Dividend
No dividend
Capital Allocation
R&D Spend$7.8M
Capex Intensity0.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Hardware | +180.0% | View detailsHardware revenue grew approximately 180% year-over-year in Q2 FY2026, showing strong execution on backlog. | |
| Software | +6.0% | View detailsSoftware revenue increased by 6% year-over-year in Q2 FY2026, supported by municipal wins in California. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.